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Dysferlin plays an important role in repairing membrane damage elicited by laser irradiation, and dysferlin deﬁciency causes
muscular dystrophy and associated cardiomyopathy. Proteins such as perforin, complement component C9, and bacteria-derived
cytolysins, as well as the natural detergent saponin, can form large pores on the cell membrane via complexation with cholesterol.
However, it is not clear whether dysferlin plays a role in repairing membrane damage induced by pore-forming reagents. In
this study, we observed that dysferlin-deﬁcient muscles recovered the tetanic force production to the same extent as their WT
counterparts following a 5-min saponin exposure (50μg/mL). Interestingly, the slow soleus muscles recovered signiﬁcantly better
than the fast extensor digitorum longus (EDL) muscles. Our data suggest that dysferlin is unlikely involved in repairing saponin-
induced membrane damage and that the slow muscle is more eﬃcient than the fast muscle in repairing such damage.
1.Introduction
Mutations in the dysferlin gene lead to the development
of several types of muscle wasting diseases including limb-
girdle muscular dystrophy type 2B (LGMD2B) [1, 2],
Miyoshi myopathy (MM) [2], and a distal anterior compart-
ment myopathy (DACM) [3], together termed dysferlinopa-
thy. Dysferlinopathy has also been shown to develop a late-
onset cardiomyopathy [4, 5]. Dysferlin is a 230kDa protein
containing multiple-tandem C2 domains, and it is widely
expressed in diﬀerent tissues and cells including skeletal and
cardiac muscle [6]. Previous work has established a role for
dysferlin in muscle membrane repair since the dysferlin-
deﬁcient skeletal [7] and cardiac [5]m u s c l ec e l l sf a i lt o
eﬃciently reseal the membrane disruptions elicited by laser
irradiation. Although the exact action of dysferlin in the
membrane repair system of striated muscle remains poorly
understood, it has been suggested that dysferlin may play a
roleinthemembranevesiclefusionstepbasedonitsprimary
structure properties [8, 9].
It is not very clear how laser irradiation induces
membrane damage, but there is evidence showing that
peroxidationoftheplasmamembranelipidsmaybeinvolved
in the photo-induced cell lysis [10, 11]. Such membrane
damage may be similar to mechanical membrane tears as
both require dysferlin and MG53 for repair at least in
muscle cells [5, 7, 12]. Interestingly, in addition to oxidation-
induced membrane damage, various pore-forming reagents
can also cause a loss of membrane integrity and cell death
in vivo. For example, perforin is released upon degranulation
of cytotoxic T cells (CTLs) and forms transmembrane pores
that promote translocation of granzymes into the cytoplasm
of pathogen-infected cells, leading to their apoptotic death
[13]. Previous studies have shown that cytotoxic T cells
contribute to muscle pathology in dystrophin-deﬁcient
muscular dystrophy through perforin-dependent as well as
perforin-independent mechanisms [14]. Cytotoxic T cells
were also found in other inﬂammatory myopathies where
they secreted perforin and invaded muscle ﬁbers [15]. In
addition, the 5th to 9th components (C5 to C9) of the
complement system is involved in terminal activation of
complement that leads to the formation of a large mem-
brane lytic pore complex—the membrane attack complex
(MAC) on the target cell membrane [16–18]. Interestingly,
the membrane inserting part of both perforin and C9 is2 Journal of Biomedicine and Biotechnology
mediated by the MACPF domain [19] which surprisingly
shares structural similarity to the bacterial cholesterol-
dependent cytolysins (CDCs) [20, 21]. Our recent study has
shown that the complement activation contributes to muscle
pathology in dysferlinopathy [22]. Moreover, the beta-
amyloid can also form ring-shaped structures reminiscent
of bacterial pore-forming toxins (PFTs) [23], which have
membrane-perforating activity [24]. Interestingly, increased
sarcolemmal and interstitial amyloid deposits were observed
in dysferlinopathy patient muscles, and mutant dysferlin
was found to be present in the amyloid deposits [25]. All
the above-mentioned pore-forming proteins (PFPs) induce
pore formation with diameters up to 50nm through a
very similar cholesterol-dependent mechanism [26]. Such
a mechanism, through complexation with cholesterol, also
applies to saponins which are natural detergents found in
many plants [27, 28].
Despite the devastating consequences of membrane per-
foration,mammaliancellscanrecovertheplasmamembrane
integrity depending on the severity and duration of the
membrane damage. For example, it has been shown that
striated myocytes can recover within seconds following
membrane damage induced by laser irradiation and micro-
electrode penetration in the presence of Ca2+, dysferlin,
and MG53 [5, 7, 12]. In addition, cells can restore plasma
membraneintegrityattheminutetimescale(<1h)following
the formation of pores (30–50nm in diameter) by CDCs
or perforin [13, 29, 30]. Removal of the pores from
the cell surface by calcium-dependent endocytosis and/or
shedding of vesicles appears to be a critical step to repair
membrane damage induced by PFPs [13, 30–32]. However,
it remains unclear whether dysferlin is involved in repairing
membranedamageinducedbyPFPs.Inthepresentstudy,we
designed experiments to address this question and provided
evidence to show that dysferlin appears to be dispensable
for membrane repair following saponin-induced membrane
damage.
2.MaterialsandMethods
2.1. Mice. All animal studies were reviewed and approved
by the Institutional Animal Care and Use Committee of
Loyola University Chicago (LU no. 202288 and LU no.
202769). The wild-type C57BL/6J (stock number: 000664),
A/J (stock number: 000646), and C57BL/6J-Chr6A/J/NaJ
(stock number: 004384) mice were obtained from the
Jackson Laboratory. Mice were maintained at Loyola Uni-
versity Medical Center Animal Facility in accordance with
animal usage guidelines. The A/J and C57BL/6J-Chr6A/J/NaJ
were genotyped by tail PCR using the following primers:
WT-F, 5 -CAAACCATTCCCAGTCCTCCT-3 ;A J - R ,5  -
AAGAGAAGGCAACAGGTGACA-3 ;A J - F ,5  -CAGAGT-
TCCAACGCCCTACT-3 . The WT allele will produce a 449-
bpband,andthemutantallelewillproducea1-kbband.The
20μL PCR reaction contained 4pmol WT-F, 4pmol AJ-F,
8pmol AJ-R primers, and 50ng of DNA extracted from mice
tails. PCR ampliﬁcation was conducted for 40 cycles under
standard conditions (denaturation at 95◦C for 30 seconds,
annealing at 58◦C for 30 seconds, and elongation at 72◦Cf o r
1 minute). The male and female mice at 12 to 24 weeks of age
were used unless otherwise speciﬁed in the text.
2.2. Antibodies. The mouse monoclonal anti-dysferlin anti-
body Hamlet (Novocastra) was used for the western blotting
and immunoﬂuorescence analyses. A monoclonal antibody
against caveolin-3 (Transduction Laboratories) and an anti-
laminin α2-chain antibody (Alexis Biochemicals) were used
for immunoﬂuorescence analysis. DAPI was used to stain
the nuclei. Peroxidase-conjugated secondary antibodies were
obtained from Roche. Alexa Fluor 488- or 555-conjugated
secondary antibodies were obtained from Invitrogen.
2 . 3 .S e r u mC r e a t i n eK i n a s eA n a l y s i s .Serum samples from
mice were obtained by tail bleeding, using a Sarstedt
microvette CB 300, from nonanesthetized restrained mice
according to institutional guidelines. Red cells were pelleted
by centrifugation at 10,000rpm for 4 minutes, and serum
was separated, collected, and analyzed immediately without
freezing. Serum creatine kinase assays were performed with
an enzyme-coupled assay reagent kit (Stanbio Laboratory)
according to the manufacturer’s instructions. Absorbance at
340nm was measured every 30sec for 2min at 37◦C so that
changes in enzyme activity could be calculated.
2.4.WesternBlotting. Muscleproteinsampleswereseparated
by SDS-PAGE and transferred onto PVDF membranes.
Membranes were blocked with 5% nonfat dry milk in TBS-
Tb u ﬀer (Tris-HCl 50mM, NaCl 150mM, pH 7.4, Tween-
20 0.1%) and incubated with primary antibodies overnight
at 4◦C. Blots were washed three times with TBS-T for 10
minutes each and incubated with Alexa Fluor 488- or 555-
conjugated secondary antibodies (1:500 dilution in TBS-T;
Invitrogen) for 1 hour at room temperature. After washing
3 × 10 minutes with TBS-T buﬀer, the membranes were
directly imaged for ﬂuorescence using the Typhoon Trio plus
imager (GE Healthcare Life Sciences, Inc.).
2.5. H&E Staining, Immunoﬂuorescence Analysis, and Central
Nucleated Fiber Counting. Histopathology studies were per-
formed as described previously [33, 34]. Several hematoxylin
and eosin stained sections (7μm) at the belly of the quadri-
ceps, iliopsoas, EDL, and soleus muscles were prepared to
characterize skeletal muscle pathology. Immunoﬂuorescence
staining was performed as described previously [33, 34].
Anti-dysferlin antibody Hamlet was used at 1:40 dilution.
Anti-caveolin-3 antibody was used at 1:1000 dilution. Anti-
laminin α2 antibody was used at 1:400 dilution. All the
secondary antibodies were used at 1:400 dilution. The
numbers of central nucleated muscle ﬁbers and the total
muscle ﬁbers were counted on muscle sections costained
with caveolin-3 and DAPI or laminin α2 and DAPI using
Image Pro Plus 6.
2.6. Contractile Force Measurement. Contractile force was
measured in vitro on extensor digitorum longus (EDL) and
soleus muscles from C57BL/6J and dysferlin-deﬁcient mice
as described previously [35]. Mice were anesthetized byJournal of Biomedicine and Biotechnology 3
an intraperitoneal (I.P.) injection of a mixture of ketamine
(87.5mg/kg) and xylazine (12.5mg/kg). Intact muscles were
removed from each mouse after the mice were euthanized
by cervical dislocation after deep anesthesia. Muscles were
immersed in an oxygenated bath (95% O2,5 %C O 2) that
contained Tyrode solution (pH 7.4) at room temperature.
For each muscle, one tendon was tied securely with a 6-0
suture (Surgical Specialties Corporation) to a force trans-
ducer/servo motor (Aurora Scientiﬁc Inc., Model: 300C-LR),
andtheothertendontoaﬁxedpin.Usingtwitcheswithpulse
duration of 0.2ms, the voltage of stimulation was increased
to achieve a maximum twitch. Twitches were then used to
adjust the muscle length to the optimum length for force
development (L0) .T h em u s c l el e n g t hw a ss e ta tL0,a n d
muscles were stimulated for 300ms. Stimulation frequency
was increased until the force reached a plateau at maximum
isometric tetanic force (P0).
2.7. Saponin Treatment. After three consecutive tetanic con-
tractions with 3 minutes intervals in between, the muscle
was incubated with saponin (Sigma) at 50μg/mL in Tyrode
solution for 5 minutes. To assess the force recovery follow-
ing saponin-induced membrane injury, tetanic contractions
were recorded starting at 10 minutes following saponin
washout, once every 10 minutes for one hour in total. The
data were digitized, collected, and analyzed using the ASI
Dynamic Muscle Control software (DMC V5.294).
2.8.StatisticalAnalysis. Datawerepresentedasmean ±SEM,
and statistical signiﬁcance (P < 0.05) was determined by
the Student’s t-test for two groups or two-way ANOVA for
multiple groups using Prism 5.02 (GraphPad). When the
overallF-ratiofortheANOVAwassigniﬁcant,thediﬀerences
betweenindividualgroupmeansweredeterminedbyasingle
Student’s t-test.
3. Results
3.1. Characterization of C57BL/6J-Chr6A/J Mice. In this
study, we employed a new dysferlin-deﬁcient mouse strain
(C57BL/6J-Chr6A/J/NaJ) from Jackson Laboratory. This
strain is an inbred C57BL/6J strain with its chromosome 6
replaced with another inbred A/J strain, originally developed
by Nadeau et al. from the Case Western Reserve University
[36]. Since the mouse dysferlin gene is located on the
chromosome 6, the C57BL/6J-Chr6A/J/NaJ mice carry the
retrotransposon insertion in the dysferlin gene that is present
in the parental A/J strain [37]. This strain is very similar to
the B6.A/J-Dysf
prmd strain used by Lostal et al. [38]e x c e p t
that the entire chromosome 6 in our strain is from A/J mice
while the B6.A/J-Dysf
prmd strain was derived by backcrossing
the A/J mice with C57BL/6J mice for 4 generations. The
C57BL/6J-Chr6A/J/NaJ mice were genotyped by a PCR
method of the tail snips as described in Section 2. A single
band of 449bp and ∼1.0kb were produced in the WT and
the homozygous mutant samples, respectively, while the
heterozygous mice yielded two major bands (449bp and
1.0kb) with additional faint nonspeciﬁc bands (Figure 1(a)).
Both western blotting and immunoﬂuorescence staining
analyses conﬁrmed that the dysferlin protein is completely
absent in the skeletal muscle of the homozygous mutant
mice (Figures 1(b) and 1(c)). H&E staining showed that the
mice developed dystrophic features (Figure 2(a)) similar to
other dysferlin-deﬁcient mice [7, 37, 38], but the dystrophic
phenotype progressed earlier and faster than the parental A/J
strain. We observed that the quadriceps muscles had sparsely
distributed necrotic muscle ﬁbers and centrally nucleated
muscle ﬁbers starting from 2 months of age and that the
numbers of such muscle ﬁbers progressively increased. The
quadriceps muscle from the male C57BL/6J-Chr6A/J mice at
4 months of age showed a slightly increased percentage of
central nucleated muscle ﬁbers compared to age- and sex-
matched A/J mice (7.3 ± 0.9% versus 4.5 ± 0.3%; N =
14 and 16; resp., P = 0.009). Compared to the quadriceps
muscle, the iliopsoas muscle from either A/J or C57BL/6J-
Chr6A/J mice had more centralnucleated muscle ﬁbers (11.9
± 3.2% and 27.4 ± 4.8%, resp.) (Figures 2(a) and 2(b)). The
serum creatine kinase level in the C57BL/6J-Chr6A/J mice at
4 months of age was signiﬁcantly elevated compared to that
in the WT controls (157 ± 42 versus 541 ± 65 IU/L; N = 6
and 10 for WT and mutant; resp., P < 0.001) (Figure 2(c)).
Thus, the C57BL/6J-Chr6A/J/NaJ strain is a true dysferlin
mutant mouse model in the C57BL/6J background (except
the chromosome 6) and was used in the following studies
(referred to as “dysferlin-deﬁcient”).
3.2. Muscle Force Recovery Following Saponin Exposure. Sap-
onins are a diverse class of natural detergents found in many
plants. Through complexation with cholesterol, saponin
perforates the cell membrane. We used saponin to induce
membrane pore formation in WT or dysferlin-deﬁcient
extensor digitorum longus (EDL) and soleus muscles and
examined force recovery following saponin treatment. Both
dysferlin-deﬁcient EDL and soleus muscles displayed a
limited overt pathology with a few centrally nucleated ﬁbers
(Figure 3), which allowed us to study the consequence of
dysferlin deﬁciency on force recovery following saponin
exposure without much preexisting dystrophic alterations.
We performed preliminary experiments to test several doses
of saponin (from 10 to 500μg / m L )a n dt r e a t e dt h eW T
E D Lm u s c l ef o re i t h e r1m i no r5m i na tr o o mt e m p e r a t u r e
(RT). We then selected 50μg/mL of saponin for 5-min
incubation, as this treatment resulted in a tetanic force
loss of ∼85% in WT EDL muscle at 10 minutes after
the treatment (Figures 4(a)–4(d)). We also tested a tetanic
contraction at one minute after saponin washout; however,
this tetanic contraction greatly decreased the ﬁnal force
recovery (data not shown). This data indicates that, by
one minute after saponin exposure, a tetanic contraction
stimulus would cause further muscle force loss. Thus, in our
standard protocol, we started the tetanic force measurement
10 minutes after saponin washout unless otherwise speciﬁed.
Upon application of saponin, the baseline tension grad-
ually increased and reached the maximum level at around
1.5 minutes after that it slowly returned to near the pre-
exposure baseline (Figure 4(b)). The increase in the baseline4 Journal of Biomedicine and Biotechnology
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Figure 1: Disrupted expression of dysferlin in skeletal muscle of C57BL/6J-Chr6A/J/NaJ mice. (a) PCR genotyping of WT (w), C57BL/6J-
Chr6A/J/NaJ (n), and heterozygous (h) mice. (b) Western blotting analysis of the quadriceps muscles from WT and C57BL/6J-Chr6A/J/NaJ
(B6.Chr6A/J) mice using the monoclonal anti-dysferlin antibody (Dysf). The bottom panel is the same blot stained with Ponceau-S (P.S).
(c) Immunoﬂuorescence labeling of muscle sections from WT and dysferlin-deﬁcient mice with anti-dysferlin antibody.
tension indicates Ca2+/Na+ entry through saponin-induced
membrane pores, while the subsequent decrease in the
muscle tension is most likely due to secondary damage inside
themusclecellaftermembranepermeabilization.Thetetanic
force gradually recovered from 15.5 ± 2.5% at 10 minutes to
42.1 ± 4.7% at 40 minutes of the initial force prior to the
treatment and did not signiﬁcantly increase further after 40
minutes (Table 1 and Figures 4(c)-4(d)). These data suggest
that the WT muscle can gradually repair the membrane
damage induced by saponin and that this repair process may
take upto30–40 minutes. The forcedid notrecoverto100%,
indicating that some irreversible damage occurred within
the muscle. Interestingly, the tetanic force also recovered to
the same level within the same time frame in the dysferlin-
deﬁcient EDL muscle following the saponin treatment
(N = 5 for either WT or mutant) (Figure 4(d) and Table 1).
These data suggest that, unlike the laser-induced membrane
damage, saponin-induced membrane damage does not seem
to require dysferlin for repair.
Next, we examined the eﬀect of saponin exposure on
the tetanic force recovery in the soleus muscle, which are
composed of predominantly slow-ﬁber type. The baseline
tension developed in soleus muscles during saponin expo-
sure was similar to that in EDL muscles (data not shown).
Surprisingly, the tetanic force recovered to ∼80% at 10
minutes after the 5-minute saponin exposure regardless of
dysferlin genotype (Figure 4(e) and Table 2). We observed
only a small but signiﬁcant increase in the tetanic force
at 20 minutes compared to that at 10 minutes, and there
was no further force recovery in the following 40 minutes
(Figure 4(e) and Table 2). To further conﬁrm that the
tetanic force was indeed rapidly recovering within the ﬁrst 10Journal of Biomedicine and Biotechnology 5
A/J quad B6.Chr6A/J quad B6.Chr6A/J psoas
200μm 200μm 200μm
(a)
W
T
-
q
u
a
d
A
/
J
-
q
u
a
d
B
6
.
C
h
r
6
A
/
J
-
q
u
a
d
A
/
J
-
p
s
o
a
s
B
6
.
C
h
r
6
A
/
J
-
p
s
o
a
s
∗∗
0
10
20
30
40
C
N
F
(
%
)
(b)
∗∗∗
KO WT
0
200
400
600
800
1000
S
e
r
u
m
C
K
(
I
U
/
L
)
(c)
Figure 2: Characterization of C57BL/6J-Chr6A/J/NaJ mice. (a) H&E-stained quadriceps (or iliopsoas) muscle sections of A/J, B6.Chr6A/J
mice. Scale bar: 200μm. (b) Central nucleated muscle ﬁber percentage (CNF) from the quadriceps or iliopsoas muscles of WT, A/J, and
B6.Chr6A/J mice at 16 weeks of age. (c) Serum creatine kinase (CK) levels from WT (N = 6) and B6.Chr6A/J (KO) (N = 10) mice at 16 weeks
of age. ∗∗indicates P < 0.05, and ∗∗∗indicates P < 0.001.
Table 1: Tetanic forces (kN/m2) of WT and dysferlin-null EDL muscles at room temperature before and after saponin exposure.
Initial 10min 20min 30min 40min 50min 60min
WT, N = 5 273.6 ± 4.9 41.9 ± 6.1 75.7 ± 10.2
(a)P = 0.002
101.7 ± 11.5
P = 0.0007
114.5 ± 11.8
P = 0.18
117.1 ± 11.8
P = 0.18
117.0 ± 11.1
P = 0.92
KO, N = 5 251.3 ± 13.5 47.5 ± 15.0 77.4 ± 14.8
P = 0.016
97.1 ± 18.3
P = 0.042
102.1 ± 19.0
P = 0.048
102.2 ± 18.7
P = 0.81
102.4 ± 18.6
P = 0.83
(b)P 0.09 0.74 0.93 0.84 0.59 0.52 0.52
Note: (a) the P values under the force data are the paired t-test of the forces at the speciﬁc time point compared to that measured at the prior time point (e.g.,
WT force at 20min compared to that at 10min); (b) the P values in the last row are the unpaired t-test of forces between WT and dysferlin-null groups at
each time point.
Table 2: Tetanic forces (kN/m2) of WT and dysferlin-null soleus muscles at room temperature before and after saponin exposure.
Initial 10min 20min 30min 40min 50min 60min
WT, N = 5 166.5 ± 6.7 130.8 ± 4.1 139.8 ± 3.6
(a)P = 0.002
137.7 ± 3.1
P = 0.32
135.0 ± 2.8
P = 0.04
133.4 ± 2.9
P = 0.75
132.2 ± 3.9
P = 0.94
KO, N = 7 171.0 ± 11.9 138.3 ± 8.4 145.6 ± 8.3
P = 0.003
142.6 ± 7.8
P = 0.15
139.7 ± 7.6
P = 0.13
138.5 ± 7.6
P = 0.34
136.9 ± 7.8
P = 0.42
(b)P 0.77 0.49 0.59 0.62 0.63 0.60 0.64
Note: (a) the P values under the force data are the paired t-test of the forces at the speciﬁc time point compared to that measured at the prior time point (e.g.,
WT force at 20min compared to that at 10min); (b) the P values in the last row are the unpaired t-test of forces between WT and dysferlin-null groups at
each time point.6 Journal of Biomedicine and Biotechnology
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Figure 3: Histology examination of EDL and soleus muscles from C57BL/6J-Chr6A/J/NaJ mice. H&E-stained EDL (top panel) and soleus
(bottom panel) muscle sections of C57BL/6J (WT) and C57BL/6J-Chr6A/J/NaJ mice. Scale bar: 100μm.
minutes, we measured tetanic force at 5 minutes following
saponin washout in four soleus muscles (two WT and two
mutants). As shown in Figure 4(e), the soleus muscles
developed 69% of maximum force at 5 minutes. By ﬁtting
the data with a one-phase association equation, we estimated
the maximum recovery percentage to be 45.9 ± 4.4% in EDL
and 84.4 ± 1.2%, and the rate of recovery to be 0.057 ± 0.025
(min−1) in EDL and 0.268 ± 0.097 (min−1)i ns o l e u s .T h i s
data suggests that the soleus muscles recovered much faster
than the EDL muscles after saponin washout.
4. Discussion
The plasma membrane deﬁnes the boundary of every single
living cell, and its integrity is essential for life. However, the
plasma membrane may be challenged by mechanical stress
during normal physiological activities or PFPs produced by
the organism itself and invading pathogens. For example,
pore formation by perforin is involved in counteracting
infection by microorganisms [19], while pore formation
by the Bcl2 family member Bax triggers apoptosis [39].
Furthermore, it has been shown that the causative agents
of Alzheimer’s or Parkinson’s disease are proteins capable of
adopting pore-forming conﬁgurations [23, 40], and pore-
forming amyloid deposits are also found in muscle diseases
[25]. Pore formation through complexation with cholesterol
and subsequent oligomerization leads to permeabilization
of ions and small molecules such as ATP and, in the case
of CDCs, leakage of proteins [26]. Repairing the membrane
damageinducedbyPFPsisthusacriticalstepfortheinﬂicted
cell to survive.
Mammalian cells have been shown to be capable of
repairing breaches in their plasma membrane. Dysferlin and
MG53 were two previously identiﬁed proteins that play
critical roles in repairing laser irradiation- and microneedle-
induced membrane damage in striated muscles [5, 7, 12,
41]. Our present study demonstrated that skeletal muscle
is also capable of repairing (at least partially) saponin-
induced membrane damage. In the case of EDL muscles,
the maximum recovery of tetanic force was around 44.6%
aftera5-minexposureto50μg/mLsaponin.Theforcedeﬁcit
indicates “permanent” damage had occurred by saponin
exposure. It is likely that the muscle ﬁbers in the outer
layers were more severely damaged because they were more
accessible to saponin. However, there were no diﬀerences
in the maximum recovery levels in the WT and dysferlin-
deﬁcient groups, suggesting that the levels of “permanent”
damage in the two groups were the same. Thus, the same
recovery rate in both WT and dysferlin-deﬁcient EDLJournal of Biomedicine and Biotechnology 7
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Figure 4: Tetanic force recovery in WT and C57BL/6J-Chr6A/J/NaJ EDL and soleus muscles following saponin exposure. (a) Representative
tetanic force measurement in a WT EDL muscle before saponin exposure. (b) Representative tension trace during saponin (50μg/mL)
exposure at room temperature (RT). (c) Representative tetanic force measurements within one hour after saponin washout at RT. Double
slash: 10min. (d) Quantitative analysis of the muscle force recovery in EDL muscles of WT and dysferlin-deﬁcient mice at RT. (e) Tetanic
force recovery in soleus muscles and EDL muscles (N = 10 and 13 for EDL and soleus, resp.) after saponin (50μg/mL) exposure at room
temperature. Note: we pooled the WT and mutant muscle data in panel (e) since there was no signiﬁcant diﬀerence between the two groups
(see Tables 1-2).
muscles suggests that dysferlin may not be involved in this
process. We do not think this data is against previous reports
showing dysferlin is required to repair laser-induced injury.
Repairing laser-induced membrane damage is dysferlin-
dependent, and this has been independently conﬁrmed by
several groups [12, 38, 42, 43]. Interestingly, the laser-
induced membrane damage is around 5μm in diameter at
only a single spot of the muscle ﬁber [5, 7, 22]. However,
the membrane pores induced by pore-forming reagents are
up to 50nm in diameter, but spread along the entire surface
of the cells in contact with the reagents. Repairing these
two diﬀerent types of membrane injuries may use diﬀerent
mechanisms [26]. Consistent with this notion, repairing
laser-induced membrane damage takes seconds (e.g., within
1-2 minutes) [5, 7, 9], but repairing the pores induced by
streptolysin O and perforin takes minutes (<1hour) [13,
29], and it takes even longer (>6h o u r s )t or e c o v e rf r o m
pore formation induced by toxins such as Staphylococcal
α-toxin [31, 44]. In our experiments, it took up to 30–
40 minutes for the EDL muscles to recover from saponin-
induced membrane damage. We, thus, interpret this data to
mean that skeletal muscle cells may use diﬀerent mechanism
to repair membrane damage induced by PFPs as compared
to laser irradiation. The detailed mechanisms leading to8 Journal of Biomedicine and Biotechnology
recovery of membrane integrity following pore formation
remain to be explored. But it has been shown that this
process involves a Ca2+-dependent and dynamin-mediated
endocyotosis coupled with exocytosis which rapidly removes
the PFPs from the cell membrane [13, 31, 32, 45].
Another interesting observation in our study is that
the slow soleus muscle recovers signiﬁcantly greater force
comparedtofastEDLmusclesuggestingthattheslowmuscle
has a more eﬃcient way to recover from saponin-induced
membrane injury. Compared to the fast EDL muscle, the
s l o ws o l e u sm u s c l eh a sm a n yd i ﬀerent properties in addition
to the diﬀerence in their contraction velocity. For example,
it was shown that the soleus muscle from a glycosylation-
deﬁcient muscular dystrophy mouse model—Largemyd—
exhibits no greater force deﬁcit compared with WT soleus
muscle [46] although the EDL muscle from the same mouse
model is highly susceptible to contraction-induced injury
[35]. This diﬀerence was attributed to the increased expres-
sion of sarcolemmal β1-integrin in the soleus muscle than
the EDL muscle [46]. The diﬀerence in the force recovery
rateuponsaponin-inducedmembraneinjurybetweensoleus
and EDL muscles remains unclear and warrants further
investigation.
In summary, we demonstrated that the skeletal muscle
possessestheabilitytorepairmembranedamagesinducedby
pore-forming reagents such as saponin. This repair process
takes 30–40 minutes for EDL muscles and up to 20 minutes
forsoleusmuscles.Finally,dysferlindeﬁciencyhaslittleeﬀect
on the recovery.
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